Tuesday, December 11, 2012- Is Teva Pharmaceutical Destined for Greatness?at Motley Fool (Tue, Dec 11)
- Jan. date to rule on BP $4.5B plea deal over spillAP (Tue, Dec 11)
- Beware The Payout Ratioat Seeking Alpha (Tue, Dec 11)
- Alexza's Adasuve May Not Be Ready For FDA Approvalat Seeking Alpha (Tue, Dec 11)
- Hemophilia Treatment Could Take A New Leapat Investor's Business Daily (Tue, Dec 11)
- Explaining Why Gilead Soared & Other BioPharma "Buys"at Motley Fool (Tue, Dec 11)
- Why Merrill Lynch Strategist Sees S&P 500 Rising 18% in 2013YCharts (Tue, Dec 11)
- Trius: The Winner In The War Against MRSAat Seeking Alpha (Tue, Dec 11)
- Biotie Rises Most in a Year on Parkinson’s Trial Resultsat Bloomberg (Tue, Dec 11)
- Report: $700,000 of Gold Dust Missing From Pfizer Labat Motley Fool (Tue, Dec 11)
- Pfizer's Pipeline Offers Diversified Product Portfolioat Seeking Alpha (Tue, Dec 11)
- Rising Dividend Stocks That Don't Care About the Fiscal Cliffat TheStreet (Tue, Dec 11)
- Rising Dividend Stocks That Don't Care About the Fiscal CliffTheStreet (Tue, Dec 11)
- Interesting Value Proposition Despite Setback - PART Iat Motley Fool (Tue, Dec 11)
- WebMD to Slash 14% of Workforce in Overhaulat Fox Business (Tue, Dec 11)
- Amgen's $415 Million Bet on the Vikingsat Motley Fool (Tue, Dec 11)
- The Zacks Analyst Blog Highlights: Merck, Pfizer, Johnson & Johnson, Sanofi and BayerZacks (Tue, Dec 11)
- The Patent Cliff's Cliffat Motley Fool (Tue, Dec 11)
- Pfizer & Bristol-Myers Squibb’s Eliquis Successful, Protalix Treats 1st Fabry Patient: Healthcare Biz Recapat Wall St. Cheat Sheet (Tue, Dec 11)
- Dragon Systems Founders Take Goldman to Trial Over Adviceat Bloomberg (Tue, Dec 11)
Monday, December 10, 2012Add PFE News to My Yahoo!   | |
|
0.06 (0.20%) 8:25AM EDT - Nasdaq Real Time Price